Video

CDC Official: Hepatitis C Virus Can Be Eliminated in the US

Author(s):

"We have drugs now that used to take one pill to several pills a day for 2-3 months, you can cure 95% of people living with hepatitis C. The issue is getting those persons identified who are living with this silent infection."

At the Conference on Retroviruses and Opportunistic Infections (CROI 2017) in Seattle, Washington, John W. Ward, MD, with the Centers for Disease Control and Prevention (CDC) discussed evidence supporting the fact that the hepatitis C virus can, indeed, be eliminated in the United States by 2030.

"We have drugs now that used to take one pill to several pills a day for two to three months, you can cure 95% of people living with hepatitis C. The issue is getting those persons identified who are living with this silent infection," said Ward. He shared that half don't know their status among the 3.5 million people living with hepatitis C in the country, so the first order of business is getting them tested, made aware of their infection, then referred to a specialist.

Ward and his team are particularly interested in baby boomers (people born between 1945 and 1965). They have a six times higher risk of having this virus than other adults, because they were young adults before the virus was discovered and before prevention measures were in place. Ward highlighted that now 70% of them have moderate-to-severe liver disease - many of them are unaware of it. "We really want to send a strong message out that all providers who have baby boomers in their practice should provide this test to them.

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Nathan D. Wong, MD, PhD: Growing Role of Lp(a) in Cardiovascular Risk Assessment | Image Credit: UC Irvine
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Laurence Sperling, MD: Multidisciplinary Strategies to Combat Obesity Epidemic | Image Credit: Emory University
Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes | Image Credit: UC San Diego
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Alice Cheng, MD: Exploring the Link Between Diabetes and Dementia | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.